Patents by Inventor Stuart Swiedler

Stuart Swiedler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
    Publication number: 20080260715
    Abstract: The present invention provides a highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. The invention also provides methods for treating diseases caused all or in part by deficiencies in human N-acetylgalactosamine-4-sulfatase including MPS VI and methods for producing and purifying the recombinant precursor enzyme to a highly purified form.
    Type: Application
    Filed: May 18, 2007
    Publication date: October 23, 2008
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Minmin Qin, Gary N. Zecherle, Wai-Pan Chan, Paul A. Fitzpatrick, Stuart Swiedler, John M. Henstrand, Dan J. Wendt, Lin Chen, Christopher M. Starr
  • Precursor N-acetylgalactosamine-4 sulfatase, methods of treatment using said enzyme and methods for producing and purifying said enzyme
    Publication number: 20050287133
    Abstract: The present invention provides a highly purified recombinant, human precursor N-acetylgalactosamine-4-sulfatase and biologically active mutants, fragments and analogs thereof as well as pharmaceutical formulations comprising highly purified recombinant human precursor N-acetylgalactosamine-4-sulfatase. The invention also provides methods for treating diseases caused all or in part by deficiencies in human N-acetylgalactosamine-4-sulfatase including MPS VI and methods for producing and purifying the recombinant precursor enzyme to a highly purified form.
    Type: Application
    Filed: May 23, 2005
    Publication date: December 29, 2005
    Applicant: BIOMARIN PHARMACEUTICAL INC.
    Inventors: Minmin Qin, Gary Zecherle, Wai-Pan Chan, Paul Fitzpatrick, Stuart Swiedler, John Henstrand, Dan Wendt, Lin Chen, Christopher Starr